Selinexor with bortezomib and dexamethasone for previously treated multiple myeloma

Supporting evidence

• Evaluation report

• Draft guidance consultation committee papers (PDF 11.46 MB)

  Published:

  15 May 2024

• Final draft guidance committee papers (PDF 1.18 MB)

  Published:

  15 May 2024